Advanced Search

Technical Analysis for MGTX - MeiraGTx Holdings plc

Grade Last Price % Change Price Change
grade D 14.07 3.61% 0.49
MGTX closed up 3.61 percent on Friday, August 14, 2020, on 45 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical MGTX trend table...
Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 20 DMA Bearish 3.61%
Bollinger Band Squeeze Range Contraction 3.61%
Bollinger Band Squeeze Range Contraction -1.12%
BB Squeeze Started Range Contraction -1.12%
Older EOD signals for MGTX ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.
Technology Gene Therapy Macular Degeneration Gene Delivery Pipeline Products Adeno Associated Virus Advanced Micro Devices AAV

Is MGTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Aug 12 Did Hedge Funds Make The Right Call On MeiraGTx Holdings plc (MGTX) ?
Aug 6 MeiraGTx EPS misses by $0.14
Aug 6 MeiraGTx Reports Second Quarter 2020 Financial Results
Aug 5 MeiraGTx Expands Leadership Team with Appointment of Robert K. Zeldin, M.D. as Chief Medical Officer
Jul 27 MeiraGTx Sees Hammer Chart Pattern: Time to Buy?
Jul 20 MeiraGTx Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
Jul 17 Do Insiders Own Lots Of Shares In MeiraGTx Holdings plc (NASDAQ:MGTX)?
Jul 17 J&J gene therapy shows encouraging action in vision loss disorder
Jul 17 MeiraGTx Announces Positive Clinical Data Demonstrating Treatment with AAV-RPGR Investigational Gene Therapy Improves Vision in X-Linked Retinitis Pigmentosa Patients  
Jun 26 MeiraGTx Holdings PLC (MGTX) Moves to Strong Buy: Rationale Behind the Upgrade
See more MGTX news...

Indicators

Indicator Value
52 Week High 22.99
52 Week Low 8.82
Average Volume 123,530
200-Day Moving Average 15.66
50-Day Moving Average 13.41
20-Day Moving Average 13.72
10-Day Moving Average 13.61
Average True Range 0.83
ADX 9.17
+DI 18.29
-DI 20.72
Chandelier Exit (Long, 3 ATRs ) 12.72
Chandelier Exit (Short, 3 ATRs ) 14.48
Upper Bollinger Band 14.83
Lower Bollinger Band 12.60
Percent B (%b) 0.66
BandWidth 16.23
MACD Line 0.16
MACD Signal Line 0.09
MACD Histogram 0.0659
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.24
Resistance 3 (R3) 15.13 14.62 15.05
Resistance 2 (R2) 14.62 14.33 14.68 14.98
Resistance 1 (R1) 14.35 14.14 14.49 14.46 14.91
Pivot Point 13.84 13.84 13.91 13.90 13.84
Support 1 (S1) 13.57 13.55 13.71 13.68 13.23
Support 2 (S2) 13.06 13.36 13.12 13.16
Support 3 (S3) 12.79 13.06 13.10
Support 4 (S4) 12.90